<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0011009'>Acute</z:hpo> <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> is associated with an increased extracellular <z:chebi fb="40" ids="18243">dopamine</z:chebi> accumulation </plain></SENT>
<SENT sid="1" pm="."><plain>Attenuation or prevention of excessive <z:chebi fb="40" ids="18243">dopamine</z:chebi> accumulation alleviates the cerebral ischemic damage </plain></SENT>
<SENT sid="2" pm="."><plain><z:chebi fb="3" ids="44915">Propofol</z:chebi>, an <z:chebi fb="1" ids="38877">intravenous anesthetic</z:chebi>, has been suggested to have neuroprotective properties </plain></SENT>
<SENT sid="3" pm="."><plain>The effect of <z:chebi fb="3" ids="44915">propofol</z:chebi> on dopaminergic <z:chebi fb="65" ids="25512">neurotransmitters</z:chebi> is unclear </plain></SENT>
<SENT sid="4" pm="."><plain>The in vivo microdialysis technique was used in this study to examine the effect of <z:chebi fb="3" ids="44915">propofol</z:chebi> on <z:mpath ids='MPATH_124'>infarct</z:mpath> size and striatal <z:chebi fb="40" ids="18243">dopamine</z:chebi> accumulation in rat model of temporary middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> </plain></SENT>
<SENT sid="5" pm="."><plain>Sixteen rats were fitted with a right striatal microdialysis probe </plain></SENT>
<SENT sid="6" pm="."><plain><z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">Ischemia</z:e> was induced by inserting a 4-0 monofilament nylon suture into the middle cerebral artery </plain></SENT>
<SENT sid="7" pm="."><plain><z:chebi fb="3" ids="44915">Propofol</z:chebi> was intravenously infused in eight rats during <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> (60 min) and reperfusion (60 min) at an average dose of 36 mg/kg/h </plain></SENT>
<SENT sid="8" pm="."><plain>Control rats (n=8) received vehicle infusion </plain></SENT>
<SENT sid="9" pm="."><plain>The <z:mpath ids='MPATH_124'>infarct</z:mpath> size was determined at the end of the experiment </plain></SENT>
<SENT sid="10" pm="."><plain><z:chebi fb="3" ids="44915">Propofol</z:chebi> significantly reduced <z:mpath ids='MPATH_124'>infarct</z:mpath> size, the median (interquatile range) value was 6.84% (7.68%), significantly lower than that in the control group, which was 28.04% (32.28%) (p&lt;0.01) </plain></SENT>
<SENT sid="11" pm="."><plain>The middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> significantly increased <z:chebi fb="40" ids="18243">dopamine</z:chebi> accumulation in the striatum </plain></SENT>
<SENT sid="12" pm="."><plain><z:chebi fb="3" ids="44915">Propofol</z:chebi> infusion significantly attenuated this middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp>-induced <z:chebi fb="40" ids="18243">dopamine</z:chebi> accumulation </plain></SENT>
<SENT sid="13" pm="."><plain>The data demonstrate that <z:chebi fb="3" ids="44915">propofol</z:chebi>, when administered during <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> and reperfusion, provides neuroprotection in our middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> in rat model </plain></SENT>
<SENT sid="14" pm="."><plain>The data also suggest that attenuated <z:chebi fb="40" ids="18243">dopamine</z:chebi> accumulation may be one of the factors contributing to the neuroprotective property of <z:chebi fb="3" ids="44915">propofol</z:chebi> </plain></SENT>
</text></document>